Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/14 → 4/1/17 |
Funding
- NGM Biopharmaceuticals, Inc. (Prot#13-0103)
Prot#13-0103: A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Pharmacodynamic Activity of NGM282 in Combination with Ursodeoxycholic Acid (UDCA) Administered for 28 D
- Rinella, Mary Eugenia (PD/PI)
Project: Research project